EUVIMEDEUVIMED entdecken
Historischer BeitragOpen Access

Extrapulmonary Mycobacterium abscessus Infections, France, 2012–20201

Benoît Heid-Picard, Faiza Mougari, Anne Pouvaret, Fanny Lanternier, Zeina Awad, Emmanuelle Bille, Olivier Lortholary, Emmanuelle Cambau, Mabsc Study Group

Emerging Infectious Diseases · 2024

DOI: 10.3201/eid3011.240459 ↗

Kurz gefasst

Historischer Beitrag in der Zeitschrift Emerging Infectious Diseases, 2024. Verfasst von Benoît Heid-Picard und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Mycobacterium abscessus, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium abscessus infection is challenging to treat. Extrapulmonary M. abscessus infections (EP-MAB) are less common than pulmonary M. abscessus infections. To evaluate treatment regimens, we retrospectively analyzed consecutive microbiologically confirmed EP-MAB cases diagnosed in France during 2012-2020. We studied 45 patients with EP-MAB, including 14 bone and joint infections, 10 skin and soft tissue infections, and 8 lymph node infections. Most (62%) patients had no reported immunodeficiency. In 27 patients, EP-MAB followed healthcare-associated (44%) or environmental (16%) injuries. Of the 45 isolates, 25 were subspecies abscessus, 10 bolletii, and 9 massiliense; 1 was unidentified. Cure was achieved for 36 (80%) patients who received a median antimicrobial regimen of 6 months; 22 (55%) also underwent surgery. Four patients died, and 5 were unavailable for follow-up. EP-MAB predominantly affects immunocompetent patients after an injury; outcomes are favorable. We propose a >6-month regimen of antimicrobial therapy with consideration for surgery and regular patient reassessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium Infections, NontuberculousMycobacterium abscessusAnti-Bacterial AgentsHumansFranceMaleFemaleMiddle AgedAdultAgedRetrospective StudiesYoung AdultAdolescentAged, 80 and overHistory, 21st CenturyChild

Stichwörter der Autor:innen

FranceMycobacterium abscessusemerging communicable diseasesextrapulmonaryhealthcare-associated infectionnontuberculous mycobacteriatravel medicinetuberculosis and other mycobacteria

Substanzen

Anti-Bacterial Agents

Zitieren

APA

Heid-Picard, B., Mougari, F., Pouvaret, A., Lanternier, F., Awad, Z., Bille, E., Lortholary, O., Cambau, E., & Mabsc Study Group (2024). Extrapulmonary Mycobacterium abscessus Infections, France, 2012–20201. Emerging Infectious Diseases. https://doi.org/10.3201/eid3011.240459

Vancouver

Heid-Picard B, Mougari F, Pouvaret A, Lanternier F, Awad Z, Bille E, et al. Extrapulmonary Mycobacterium abscessus Infections, France, 2012–20201. Emerging Infectious Diseases. 2024. doi:10.3201/eid3011.240459

BibTeX
@article{HeidPicard2024,
  author = {Heid-Picard, Benoît and Mougari, Faiza and Pouvaret, Anne and Lanternier, Fanny and Awad, Zeina and Bille, Emmanuelle and Lortholary, Olivier and Cambau, Emmanuelle and Mabsc Study Group, Mabsc Study Group},
  title = {Extrapulmonary Mycobacterium abscessus Infections, France, 2012–20201},
  journal = {Emerging Infectious Diseases},
  year = {2024},
  doi = {10.3201/eid3011.240459}
}
Kostenlos starten →